Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$118.38 - $210.04 $136,728 - $242,596
1,155 New
1,155 $207,000
Q4 2021

Jan 21, 2022

SELL
$225.82 - $368.51 $893,118 - $1.46 Million
-3,955 Closed
0 $0
Q3 2021

Oct 26, 2021

BUY
$221.9 - $484.47 $877,614 - $1.92 Million
3,955 New
3,955 $1.52 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Patton Fund Management, Inc. Portfolio

Follow Patton Fund Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patton Fund Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Patton Fund Management, Inc. with notifications on news.